Development of Cryptosporidium parvum-induced gastrointestinal neoplasia in severe combined immunodeficiency (SCID) mice: Severity of lesions is correlated with infection intensity

American Journal of Tropical Medicine and Hygiene

Volumn 82, Issue 2, 2010, Pages 257-265

  Certad, Gabriela ^a   Creusy, Colette ^b   Ngouanesavanh, Tramy ^a   Guyot, Karine ^c   Gantois, Nausicaa ^c   Mouray, Anthony ^a   Chassat, Thierry ^a   Flament, Nicolas ^a   Fleurisse, Laurence ^b   Pinon, Anthony ^a   Delhaes, Laurence ^c,d   Dei Cas, Eduardo ^c,d  

^a INSTITUT PASTEUR DE LILLE   (France)

^b UNIVERSITÉ CATHOLIQUE DE LILLE   (France)

^c UNIV LILLE   (France)

^d LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; DEXAMETHASONE; KI 67 ANTIGEN; IMMUNOSUPPRESSIVE AGENT; MKI67 PROTEIN, MOUSE;

ADENOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; CRYPT CELL; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; DIGESTIVE SYSTEM CANCER; DISEASE COURSE; DISEASE SEVERITY; DYSPLASIA; FEMALE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INOCULATION; INTESTINE TUMOR; MOUSE; NONHUMAN; SEVERE COMBINED IMMUNODEFICIENCY; ANIMAL; GASTROINTESTINAL TUMOR; GENE EXPRESSION REGULATION; METABOLISM; MOUSE MUTANT; PARASITOLOGY;

ANIMALIA; CRYPTOSPORIDIUM; CRYPTOSPORIDIUM PARVUM; MUS;

ANIMALS; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; DEXAMETHASONE; GASTROINTESTINAL NEOPLASMS; GENE EXPRESSION REGULATION; IMMUNOSUPPRESSIVE AGENTS; KI-67 ANTIGEN; MICE; MICE, SCID;

EID: 77449151080     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2010.09-0309     Document Type: Article

References (33)

1. Sunnotel O, Lowery CJ, Moore JE, Dooley JS, Xiao L, Millar BC, Rooney PJ, Snelling WJ, 2006. Cryptosporidium. Lett Appl Microbiol 43: 7-16.
2. Pozio E, Morales MA, 2005. The impact of HIV-protease inhibitors on opportunistic parasites. Trends Parasitol 21: 58-63.
3. Okhuysen PC, Chappell CL, 2002. Cryptosporidium virulence determinants-are we there yet? Int J Parasitol 32: 517-525.
4. Izquierdo J, Antunez I, Calderon MT, Perez Giraldo C, Munoz Sanz A, 1988. Diarrhea caused by Cryptosporidium and colonic neoplasia. Rev Clin Esp 182: 393-394.
5. Sulzyc-Bielicka V, Kuzna-Grygiel W, Kolodziejczyk L, Bielicki D, Kladny J, Stepien-Korzonek M, Telatynska-Smieszek B, 2007. Cryptosporidiosis in patients with colorectal cancer. J Parasitol 93: 722-724.
6. Certad G, Ngouanesavanh T, Guyot K, Gantois N, Chassat T, Mouray A, Fleurisse L, Pinon A, Cailliez JC, Dei-Cas E, Creusy C, 2007. Cryptosporidium parvum, a potential cause of colic adenocarcinoma. Infect Agent Cancer 2: 22.
7. Mele R, Gomez Morales MA, Tosini F, Pozio E, 2004. Cryptosporidium parvum at different developmental stages modulates host cell apoptosis in vitro. Infect Immun 72: 6061-6067.
8. Lowe SW, Lin AW, 2000. Apoptosis in cancer. Carcinogenesis 21: 485-495.
9. Mead JR, Ilksoy N, You X, Belenkaya Y, Arrowood MJ, Fallon MT, Schinazi RF, 1994. Infection dynamics and clinical features of cryptosporidiosis in SCID mice. Infect Immun 62: 1691-1695.
10. Kang M, Mitomi H, Sada M, Tokumitsu Y, Takahashi Y, Igarashi M, Katsumata T, Okayasu 1, 1997. Ki-67, p53, and Bcl-2 expression of serrated adenomas of the colon. Am J Surg Pathol 21: 417-423.
11. Stojadinovic O, Lee B, Vouthounis C, Vukelic S, Pastar I, Blumenberg M, Brem H, Tomic-Canic M, 2007. Novel genomic effects of glucocorticoids in epidermal keratinocytes: inhibition of apoptosis, interferon-gamma pathway, and wound healing along with promotion of terminal differentiation. J Biol Chem 282: 4021-4034.
12. Guyot K, Gireaudot-Liepmann MF, Cabon A, Riveau-Ricard I, Lange M, Delattre JM, Dei-Cas E, 2000. Influence of US Epa 1622 method successive steps on the viability of Cryptosporidium oocysts. Water Sci Technol 41: 189-196.
13. Rasmussen KR, Healey MC, 1992. Experimental Cryptosporidium parvum infections in immunosuppressed adult mice. Infect Immun 60: 1648-1652.
14. Boivin GP, Washington K, Yang K, Ward JM, Pretlow TP, Russell R, Besselsen DG, Godfrey VL, Doetschman T, Dove WF, Pitot HC, Halberg RB, Itzkowitz SH, Groden J, Coffey RJ, 2003. Pathology of mouse models of intestinal cancer: consensus report and recommendations. Gastroenterology 124: 762-777.
15. Dommels YE, Butts CA, Zhu S, Davy M, Martell S, Hedderley D, Barnett MP, McNabb WC, Roy NC, 2007. Characterization of intestinal inflammation and identification of related gene expression changes in mdr1a(-/-) mice. Genes Nutr 2: 209-223.
16. Aparicio T, Kotelevets L, Tsocas A, Laigneau JP, Sobhani I, Chastre E, Lehy T, 2005. Leptin stimulates the proliferation of human colon cancer cells in vitro but does not promote the growth of colon cancer xenografts in nude mice or intestinal tumorigenesis in Apc(Min/+) mice. Gut 54: 1136-1145.
17. Polyak K, Hamilton SR, Vogelstein B, Kinzler KW, 1996. Early alteration of cell-cycle-regulated gene expression in colorectal neoplasia. Am J Pathol 149: 381-387.
18. Nonoyama S, Smith FO, Bernstein ID, Ochs HD, 1993. Strain-dependent leakiness of mice with severe combined immune deficiency. J Immunol 150: 3817-3824.
19. Aliouat EM, Martinez A, Jimenez E, Dei-Cas E, Mullet C, Delcourt P, Gargallo-Viola D, 1997. Development of Pneumocystosis animal models: corticosteroid-treated Wistar rat; SCID mouse and nude rat. J Eukaryot Microbiol 44: 41S-42S.
20. Dann SM, Wang HC, Gambarin KJ, Actor JK, Robinson P, Lewis DE, Caillat-Zucman S, White AC Jr, 2005. Interleukin-15 activates human natural killer cells to clear the intestinal protozoan Cryptosporidium. J Infect Dis 192: 1294-1302.
21. Chappell CL, Okhuysen PC, Sterling CR, DuPont HL, 1996. Cryptosporidium parvum: intensity of infection and oocyst excretion patterns in healthy volunteers. J Infect Dis 173: 232-236.
22. Levine ND, 1973. Protozoan Parasites of Domestic Animals and of Man. Minneapolis, MN: Burgess Publishing Company, 156-254.
23. Mead JR, Arrowood MJ, Sidwell RW, Healey MC, 1991. Chronic Cryptosporidium parvum infections in congenitally immunodeficient SCID and nude mice. J Infect Dis 163: 1297-1304.
24. Mead JR, Arrowood MJ, Healey MC, Sidwell RW, 1991. Cryptosporidial infections in SCID mice reconstituted with human or murine lymphocytes. J Protozool 38: 59S-61S.
25. Stephens J, Cosyns M, Jones M, Hayward A, 1999. Liver and bile duct pathology following Cryptosporidium parvum infection of immunodeficient mice. Hepatology 30: 27-35.
26. Shih IM, Wang TL, Traverso G, Romans K, Hamilton SR, Ben-Sasson S, Kinzler KW, Vogelstein B, 2001. Top-down morphogenesis of colorectal tumors. Proc Natl Acad Sci USA 98: 2640-2645.
27. Scoazec JY, 2007. Dysplasia in glandular digestive tissues: new concepts, new classifications. Ann Pathol 27: 398-416.
28. Stolte M, 2003. The new Vienna classification of epithelial neoplasia of the gastrointestinal tract: advantages and disadvantages. Virchows Arch 442: 99-106.
29. Luperchio SA, Schauer DB, 2001. Molecular pathogenesis of Citrobacter rodentium and transmissible murine colonic hyperplasia. Microbes Infect 3: 333-340.
30. Uhl EW, Jacobson E, Bartick TE, Micinilio J, Schimdt R, 2001. Aural-pharyngeal polyps associated with Cryptosporidium infection in three iguanas (Iguana iguana). Vet Pathol 38: 239-242.
31. Heine J, Moon HW, Woodmansee DB, 1984. Persistent Cryptosporidium infection in congenitally athymic (nude) mice. Infect Immun 43: 856-859.
32. Dobbelaere DA, Fernandez PC, Heussler VT, 2000. Theileria parva: taking control of host cell proliferation and survival mechanisms. Cell Microbiol 2: 91-99.
33. Heussler VT, Kuenzi P, Rottenberg S, 2001. Inhibition of apoptosis by intracellular protozoan parasites. Int J Parasitol 31: 1166-1176.